Mackay Gold & Silver to Acquire Comstock Inc.'s Nevada Mining Assets, Creating the Largest Consolidated Land Package in the History of the Historic Comstock Gold-Silver District
Mackay Gold & Silver Announces Listing on the OTCQB Under the Symbol "MKGSF"
Arthur J. Gallagher & Co. Acquires MACK Insurance Services
Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock
Merrimack Pharmaceuticals Announces Notification of Plan to Voluntary Delist Common Stock on NASDAQ Subject to Receipt of Stockholder Approval of Plan of Dissolution
Merrimack Receives $225 Million Milestone Payment from Ipsen
Merrimack Reports Full Year 2023 Financial Results
Merrimack Reports Ipsen Announcement of Approval By The US FDA of Onivyde® (Irinotecan Liposome Injection) Plus 5 Fluorouracil/Leucovorin and Oxaliplatin (NALIRIFOX) as a First-Line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
Merrimack Reports Third Quarter 2023 Financial Results
Merrimack Reports Second Quarter 2023 Financial Results
Virpax Pharmaceuticals Reports 2023 First Quarter Results and Recent Developments
Virpax Pharmaceuticals To Present at Upcoming CB Tech Watch Seminar
Nuss Truck & Equipment Launches e-Emphasys Dealer Management Platform
Seven Neal Gerber Eisenberg Attorneys Recognized for Excellence in Pro Bono Service
Merrimack Reports First Quarter 2023 Financial Results
Virpax Pharmaceuticals to Present at Sidoti Virtual Investor Conference May 10-11, 2023
CareFirst BlueCross BlueShield Reimagines Weight Management and Diabetes Prevention with Noom
Claros Mortgage Trust, Inc. Reports First Quarter 2023 Results
Wells Fargo Foundation Awards $7.5 Million to Habitat for Humanity to Build, Repair Homes
Virpax Pharmaceuticals Engages Dr. Pardeep Gupta to Assist in Development of Company’s Lead Asset, Probudur™
Merrimack Still Has Significant Arbitrage Potential
Merrimack Pharmaceuticals (MACK) Stock Skyrockets Over 240%: Details
3 Biotech Penny Stocks To Watch After MACK Stock Jumps 240%
Merrimack stock rockets 200% after positive trial data on Onivyde pancreatic cancer treatment
Return Of The Mack: A Deeply Misunderstood Near-Term Readout
Merrimack Reports Second Quarter 2021 Financial Results
Merrimack Reports Full Year 2020 Financial Results
Merrimack Reports Second Quarter 2020 Financial Results
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) Insider Sells $363,326.04 in Stock
Merrimack Reports First Quarter 2020 Financial Results
US Stock Market Weekly Update March 30- April 3, 2020
The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test
The Daily Biotech Pulse: Mylan Ramps Up Manufacturing Of Potential COVID-19 Drug, Lexicon Stops Study Early, Masimo To Buy German Ventilation Company
The Daily Biotech Pulse: Mylan Ramps Up Manufacturing Of Potential COVID-19 Drug, Lexicon Stops Study Early, Masimo To Buy German Ventilation Company
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates
The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
The Daily Biotech Pulse: Gilead Kicks Off Coronavirus Drug Trials, Adcom Nod For Lily, FDA Approves Esperion's Lipid-Lowering Adjunctive Combo Therapy
The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves Into Clinics
The Daily Biotech Pulse: Axovant Surges On Gene Therapy Study Results, FDA Approves Merck's Ebola Vaccine, Abeona Announces Offering